We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LEVOTHRYOXINE GH (Lupin Australia Pty Limited)
Product name
LEVOTHRYOXINE GH
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
133 (255 working days)
Active ingredients
levothyroxine sodium
Registration type
New generic medicine
Indication
Levothyroxine Lupin, Levothyroxine LAPL and Levothyroxine GH is indicated for the management of demonstrated thyroid hormone deficiency.
Levothyroxine Lupin, Levothyroxine LAPL and Levothyroxine GHis also used to suppress thyrotropin (TSH) for the management of TSH-responsive tumours of the thyroid.